The rise of nanomedicine has led to the regulatory approval of more than 80 nanoparticle (NP)-based therapeutics over the past two decades. Further advancement in the field requires a deeper understanding of the nano-bio interface of NPs, including their uptake, delivery, efficacy, toxicity, and adverse effects. Despit...
Yasmine Radwan, Laura P. Rebolledo, Elizabeth Skelly et al.· Chemical Society Reviews· 0 citations
It is confirmed that enhanced host immune activation and direct antibacterial activity result in a significant reduction of intracellular S. aureus in primary murine osteoblasts, highlighting the therapeutic potential of this platform.
Leyla Danai, Christina J. Bayard, Krishna Majithia et al.· ACS nano medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.